Friday, 30 April 2021

Serum Institute Plans To Begin Vaccine Production Outside India: Report

The Serum Institute of India, which manufactures the AstraZeneca COVID-19 vaccine, is planning to start vaccine production in other countries as it struggles to meet supply commitments, its chief...

from NDTV News - Special https://ift.tt/3taGuT3
via
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Rs 5 Lakh Lump Sum vs Rs 5,000 Monthly SIP: Which Creates More Wealth?

Lump sum and Systematic Investment Plan (SIP) are two popular ways of investing in mutual funds. While lump sum involves investing a large a...